Transcript Aventis Pharma Aventis Group

Aventis Pharma
1
Aventis Pharma
Aventis Pharma
Prescription drugs
Aventis Pharma
Vaccines
Aventis Pasteur
Therapeutic proteins
Aventis Behring
Diagnostics
Dade Behring
2
Key Figures
• 92, 500 employees – 80% in Pharma
• 16 Bn€ Pharma sales – 5th in top 10
• Strong & growing US presence with >35% sales
• 19,000 member sales force
• 16.8% R&D expenditure; 6500 scientists & technicians
worldwide
• 15% of R&D expenditure dedicated to alliances; about 50
major biotech collaborations; about 250 academic
collaborations
3
Drug Innovation & Approval (R&D)
Disease Groups supported by powerful technology platforms
• ~6500 scientists & technicians worldwide
Asian Drug Devt Ctr
US
Global and US Drug Devt
Ctr
- Immunology platform
- Respiratory diseases
- RA
- CNS
*
Gene Therapy
European Drug
Devt Ctr
FRANCE
- Oncology,
- Infectious Diseases
- Neurodegenerative
Diseases,
(Parkinson
& Alzheimer),
JAPAN
GERMANY
-CV
- Metabolic Diseases,
- Osteoarthritis,
Thrombosis
4
Drug Innovation & Approval in
France
CDG Airport
SEINE ST DENIS
HAUTS DE SEINE
Romainville
PARIS
• Paris Research Centre
• European Drug Devt Centre
• ~2800 scientists & technicians
Vitry-Alfortville
Croix de Berny
VAL DE MARNE
ESSONNE
5 km
Evry
5
New drug discovery technologies
Preclinical
Target
Lead
Candidate
Candidate PhI / IIa PhIIb PhIII Regulatory
SelectionIdentification Identification Identification
Review
Functional Genomics
Technologies DNA chips
Proteomics, cellular & animal models..
Lead Identification
Technologies MedChem,
ChemBiol, Structural Genomics and
Biology….
Technologies for Exploratory
Development
eADMET, TGX, PGX,
Biomarkers….
Technologies for Global Rapid
submissions
e-submissions…..
Integrated Data and Knowledge Management
6
Metabolism Oncology
CNS / ND
Cardiovascular
Rheumatoid Arthritis
Osteoarthritis - DJD
Respiratory Diseases
Anti-Infectives
Immunology platform
Disease
Biology
Platforms
Genomics
Technology
Platforms
Aventis Genomics
Centers
Targets relevant to disease
7
External Collaborations &
Networks
External Collaborations &
Networks
Integration of Genomics Technologies &
Disease Biology Platforms
Key Challenges
• The post-human genome sequence race
•
•
•
•
•
functional genomics
proteomics
protein structure prediction
re-thinking chemical approaches
re-thinking clinical development
• Continuous integration of technologies (alliances and
partnering), information and knowledge (knowledge
networks)
• Availability of skilled work force (right skill-set and mind-set)
8
Post-doc Opportunities in Aventis Pharma,
France
In partnership with the European
Commission: 12 Marie Curie Industry Host
Fellowships
for a 2 year period.
•Parkinson’s Disease Gene Targets (3 positions)
•Molecular Modeling and High Throughput Medicinal Chemistry (3 positions)
•From Protein-Protein Interactions (yeast 2H) to Lead Discovery Process (3pos
•Bio-Informatics in Toxicogenomics (1 position)
•Cardiovascular Gene Therapy (1 position)
•Adenoviral Vector-based system for Functional Genomics (1 position)
Immediate Starting
Date
9
Post-doc Opportunities in Aventis Pharma,
France
In partnership with the European
The position are openCommission
to members of the E.C. or
resident of associated countries for more than 5
years.
The age limit at the time of selection is 35 years old.
Austria,
Belgium,
Bulgaria,
Czech republic,
Denmark,
Estonia,
Finland,
Germany
Greece,
Hungary,
Iceland,
Ireland,
Israel,
Italy,
Latvia,
Liechtenstein
Lithuania,
Luxembourg,
Netherlands,
Norway,
Poland,
Portugal,
Republic of
Cyprus,
Romania
Slovakia,
Slovenia,
Sweden,
Spain,
United Kingdom
However French citizens are ineligible as well as those who have been resident in
France for more than 12 out of the last 24 months.
10
Post-doc Opportunities in Aventis Pharma,
France
Coming soon
9 post-doctoral positions
•Statistics for Pharmacogenetics
•Kinases in Oncology and Neurodegenerative diseas
•Gene Transfer in Angiogenesis
•Genomic Studies for the glial-neuronal interactions
11
Post-doc Opportunities in Aventis Pharma,
France
• Project Team
• Networking
• Publications/patents
• Confidentiality
• 250 KF/year (38KEuros/yea
• Social security included
• 26 + 12 days holiday
12
Come and join us on the Aventis stand to learn more
about our post-doctoral opportunities !
[email protected]
13